Return to program book search

Session Information

SYM S037 - What's New in Blistering Disease

Open admission to eligible categories, no tuition or ticket

Subject:

Date: Sunday, March 03

CME Credits: 3.00

Location: Room C220/221/222

Time: 2:00 PM - 5:00 PM

Director: David T. Woodley, MD, FAAD - Handout

Speakers:

  • Grant J. Anhalt, MD, FAAD
  • Donna Culton, MD, PhD, FAAD - Handout
  • Janet A. Fairley, MD, FAAD
  • Russell P. Hall, III, MD, FAAD
  • Michael Kasperkiewicz, MD
  • Dedee F. Murrell, MD, FAAD - Handout

Learning Objectives:
Following this course, the attendee should be able to:

  • Recognize the pathogenesis of selected autoimmune bullous diseases.
  • Recognize the pathogenesis of selected hereditary bullous diseases
  • Determine appropriate therapeutic strategies for selected autoimmune and hereditary skin disorders.

Description:
This symposium is designed to bring to the AAD members up-to-date information about the diagnosis and treatment of selected autoimmune and hereditary bullous diseases. State-of-the-art diagnostic criteria and therapy will be discussed, as will new avenues of treatment under development or in early clinical trials.

Schedule:

Sunday, March 03
2:00 PMWelcome / Dr. Woodley
2:05 PMThe Use of Rituximab in Autoimmune Blistering Disorders / Dr. Culton
2:25 PMQuestions & Answers / Dr. Culton
2:30 PMUpdate on Pemphigus Pathogenesis and Treatment / Dr. Anhalt
2:50 PMQuestions & Answers / Dr. Anhalt
2:55 PMUpdate on Dermatitis Herpetiformis / Dr. Hall
3:15 PMQuestions & Answers / Dr. Hall
3:20 PMCell Therapy for Recessive Dystrophic Epidermolysis Bullosa / Dr. Murrell
3:40 PMQuestions & Answers / Dr. Murrell
3:45 PMImmunoabsorption Therapy for Autoimmune Bullous Diseases / Dr. Kasperkiewicz
4:05 PMQuestions & Answers / Dr. Kasperkiewicz
4:10 PMUpdate on IgE and Autoimmunity: BP As A Protype / Dr. Fairley
4:30 PMQuestions & Answers / Dr. Fairley
4:35 PMEBA Update & Relationship To Inflammatory Bowel Disease / Dr. Woodley
4:55 PMQuestions & Answers / Dr. Woodley